232 related articles for article (PubMed ID: 20633182)
1. Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: international consensus statement.
Reddihough D; Erasmus CE; Johnson H; McKellar GM; Jongerius PH;
Eur J Neurol; 2010 Aug; 17 Suppl 2():109-21. PubMed ID: 20633182
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.
Lin YC; Shieh JY; Cheng ML; Yang PY
Neurology; 2008 Jan; 70(4):316-8. PubMed ID: 18209205
[No Abstract] [Full Text] [Related]
3. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
6. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
7. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
[TBL] [Abstract][Full Text] [Related]
9. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
Hay N; Penn C
Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
[TBL] [Abstract][Full Text] [Related]
10. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
Turk-Gonzales M; Odderson IR
Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
[TBL] [Abstract][Full Text] [Related]
11. Onabotulinum toxin A for the treatment of sialorrhea in familial dysautonomia.
Daniel SJ; Cardona I
Int J Pediatr Otorhinolaryngol; 2014 May; 78(5):879-81. PubMed ID: 24725647
[TBL] [Abstract][Full Text] [Related]
12. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
13. [Drooling in neuropediatric patients].
Steffen A; Ortfeld S; Schönweiler R
Klin Padiatr; 2011 Jan; 223(1):5-9. PubMed ID: 21271513
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin A as a treatment for excessive drooling in children.
Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
[TBL] [Abstract][Full Text] [Related]
15. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
Bekkers S; Pruijn IMJ; Van Hulst K; Delsing CP; Erasmus CE; Scheffer ART; Van Den Hoogen FJA
Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393
[TBL] [Abstract][Full Text] [Related]
16. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS
J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
[TBL] [Abstract][Full Text] [Related]
17. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
Erasmus CE; van Hulst K; Scheffer AR; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
[TBL] [Abstract][Full Text] [Related]
18. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided botulinum toxin injections for treatment of drooling.
Breheret R; Bizon A; Jeufroy C; Laccourreye L
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
[TBL] [Abstract][Full Text] [Related]
20. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
